196 related articles for article (PubMed ID: 37316363)
1. The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review.
Mpakogiannis K; Fousekis FS; Christodoulou DK; Katsanos KH; Narula N
Dig Liver Dis; 2023 Oct; 55(10):1311-1317. PubMed ID: 37316363
[TBL] [Abstract][Full Text] [Related]
2. Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review.
Steenholdt C; Dige Ovesen P; Brynskov J; Benedict Seidelin J
J Crohns Colitis; 2023 Aug; 17(8):1354-1363. PubMed ID: 36860164
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Berinstein JA; Sheehan JL; Dias M; Berinstein EM; Steiner CA; Johnson LA; Regal RE; Allen JI; Cushing KC; Stidham RW; Bishu S; Kinnucan JAR; Cohen-Mekelburg SA; Waljee AK; Higgins PDR
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2112-2120.e1. PubMed ID: 34048936
[TBL] [Abstract][Full Text] [Related]
4. Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis.
Gilmore R; Hilley P; Srinivasan A; Choy M; De Cruz P
J Crohns Colitis; 2022 Jan; 16(1):166-168. PubMed ID: 34159363
[TBL] [Abstract][Full Text] [Related]
5. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
Kotwani P; Terdiman J; Lewin S
J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
[TBL] [Abstract][Full Text] [Related]
6. Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
Resál T; Bacsur P; Keresztes C; Bálint A; Bor R; Fábián A; Farkas B; Katsanos K; Michalopoylos G; Ribaldone DG; Attauabi M; Zhao M; Barak HA; Yanai H; Bezzio C; Rispo A; Castiglione F; Bar-Gil Shitrit A; Pugliese D; Armuzzi A; Savarino EV; Kolar M; Lukáš M; Chashkova E; Filip R; Rozieres A; Nancey S; Krznarić Ž; Schäfer E; Szamosi T; Sarlós P; Franko M; Drobne D; Knyazev OV; Kagramanova AV; Limdi J; Wetwittayakhlang P; Lakatos PL; Maharshak N; Bannon L; Nyári T; Szepes Z; Farkas K; ; Molnár T
Inflamm Bowel Dis; 2024 May; 30(5):768-779. PubMed ID: 37542737
[TBL] [Abstract][Full Text] [Related]
7. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.
Xiao Y; Benoit N; Sedano R; Jairath V; Narula N; McCurdy JD; Rosenfeld G; Afif W; Lakatos PL; Bessissow T
Dig Dis Sci; 2022 Nov; 67(11):5213-5219. PubMed ID: 35244825
[TBL] [Abstract][Full Text] [Related]
9. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
Lair-Mehiri L; Stefanescu C; Vaysse T; Laharie D; Roblin X; Rosa I; Treton X; Abitbol V; Amiot A; Bouguen G; Dib N; Fumery M; Pariente B; Carbonnel F; Peyrin-Biroulet L; Simon M; Viennot S; Bouhnik Y
Dig Liver Dis; 2020 Mar; 52(3):268-273. PubMed ID: 31732444
[TBL] [Abstract][Full Text] [Related]
10. Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
Carvalhas Gabrielli AM; Ferretti F; Monico CM; Tombetti E; Maconi G; Romeo S; Piazza O Sed N; Caprioli F; Mazzola AM; Alicante S; Bertè R; Lolli E; Scribano ML; Buscarini E; Ricci C; Carmagnola S; Ardizzone S; Cannatelli R
Dig Dis Sci; 2024 May; 69(5):1785-1792. PubMed ID: 38530500
[TBL] [Abstract][Full Text] [Related]
11. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
Sebastian S; Walker GJ; Kennedy NA; Conley TE; Patel KV; Subramanian S; Kent AJ; Segal JP; Brookes MJ; Bhala N; Gonzalez HA; Hicks LC; Mehta SJ; Lamb CA;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):271-281. PubMed ID: 33545083
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.
Berinstein JA; Steiner CA; Regal RE; Allen JI; Kinnucan JAR; Stidham RW; Waljee AK; Bishu S; Aldrich LB; Higgins PDR
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):988-990.e1. PubMed ID: 30458248
[TBL] [Abstract][Full Text] [Related]
13. Successful initial tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: a case series.
Komeda Y; Kono M; Kashida H; Tribonias G; Masaki S; Takada R; Nagai T; Hagiwara S; Nishida N; Takenaka M; Honjo H; Matsui S; Tsuji N; Kudo M
Ann Gastroenterol; 2023; 36(1):97-102. PubMed ID: 36593812
[TBL] [Abstract][Full Text] [Related]
14. Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study.
Parra-Izquierdo V; Frías-Ordoñez JS; Juliao-Baños F; Cuadros C; Romero Sanchez C; Flórez-Sarmiento C
Gastroenterol Hepatol; 2024; 47(6):582-590. PubMed ID: 37806342
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.
Rowan C; Yeaman F; Ernest-Suarez K; Martin ML; Panaccione R; Shukla T; Grossi M; Vlasschaert M; Novak K; Seow C
Inflamm Bowel Dis; 2024 May; 30(5):868-870. PubMed ID: 38591862
[TBL] [Abstract][Full Text] [Related]
16. Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
Zhou HY; Guo B; Lufumpa E; Li XM; Chen LH; Meng X; Li BZ
Immunol Invest; 2021 May; 50(4):323-337. PubMed ID: 32009472
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis.
Malakar S; Kothalkar S; Shamsul Hoda U; Ghoshal UC
Cureus; 2023 Sep; 15(9):e45416. PubMed ID: 37854768
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.
Loftus EV; Baumgart DC; Gecse K; Kinnucan JA; Connelly SB; Salese L; Su C; Kwok KK; Woolcott JC; Armuzzi A
Inflamm Bowel Dis; 2023 May; 29(5):744-751. PubMed ID: 35792493
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India.
Mundhra S; Thomas D; Jain S; Sahu P; Vuyyuru S; Kumar P; Kante B; Panwar R; Sahni P; Chaudhry R; Das P; Makharia G; Kedia S; Ahuja V
Indian J Gastroenterol; 2023 Jun; 42(3):411-417. PubMed ID: 37171781
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials.
Panés J; Vermeire S; Dubinsky MC; Loftus EV; Lawendy N; Wang W; Salese L; Su C; Modesto I; Guo X; Colombel JF
J Crohns Colitis; 2021 Nov; 15(11):1852-1863. PubMed ID: 33884415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
